News3 days ago
Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-Class ADC Pipeline
Strengthening of strategic option license agreement to cover additional novel ADC targets COPENHAGEN, Denmark, May 30, 2023 /PRNewswire/ — Adcendo ApS (“Adcendo”), a biotech company focused...
